close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Lemonade Inc U/S/ Markets PepsiCo Inc/
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Dexcom Inc Tempus AI Inc US: News
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Novo Nordisk A/S Biotechnology Health care policy
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Asia Markets Intel Corp Novo Nordisk A/S
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Business News LILLY DRN Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Pharmaceuticals Novo Nordisk A/S Breaking News: Europe
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags AstraZeneca PLC Roche Holding AG Merck & Co Inc
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags BE Semiconductor Industries NV Economy Dassault Systemes SE
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Biotech and Pharmaceuticals Health care industry Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Novo Nordisk A/S LILLY DRN Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Companies Biotechnology Business News
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Prescription drugs Social media Health care industry
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc Novo Nordisk A/S Healthy Returns
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Weight management Goodrx Holdings Inc Business News
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Investment strategy Tesla Inc Breaking News: Markets
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Biotech and Pharmaceuticals Health care industry LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Nordstrom Inc Economy 5 Things to Know
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Breaking News: Business Novo Nordisk A/S Amgen Inc
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Novo Nordisk A/S LILLY DRN Amgen Inc
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Biotech and Pharmaceuticals Science Health & Science
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Health care industry Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Business US: News Science
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags Novo Nordisk A/S Food and Drug Administration HIMS
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Social issues Healthy Returns LILLY DRN
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Health & Science Health care industry Pharmaceuticals
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Biotech and Pharmaceuticals Health & Science Health care industry
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Business Investment strategy S&P 500
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Europe News Novo Nordisk A/S LILLY DRN
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Novo Nordisk A/S Crime Business News
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today